These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 3486913
1. Molecular, serologic, and functional evidence for an apparent HLA-DR triplet. Bontrop RE, Schreuder GM, Elferink DG, Mikulski MM, Geerse R, Giphart MJ. J Immunol; 1986 Jul 01; 137(1):211-6. PubMed ID: 3486913 [Abstract] [Full Text] [Related]
2. A family with an apparent HLA-DR triplet: evidence for exchange of functional HLA-DR beta-genes between different haplotypes. Tilanus MG, van Eggermond MC, Fei HM, Schreuder GM, Giphart MJ. Exp Clin Immunogenet; 1989 Jul 01; 6(2):162-8. PubMed ID: 2576521 [Abstract] [Full Text] [Related]
3. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines. Maeda H, Hirata R. J Immunol; 1984 Feb 01; 132(2):574-7. PubMed ID: 6418807 [Abstract] [Full Text] [Related]
4. Biochemistry of HLA-DRw6: evidence for seven distinct haplotypes. Haziot A, Lepage V, Freidel AC, Betuel H, Degos L, Charron DJ. J Immunol; 1986 May 15; 136(10):3767-72. PubMed ID: 3486222 [Abstract] [Full Text] [Related]
5. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression. Edwards JA, Durant BM, Jones DB, Evans PR, Smith JL. J Immunol; 1986 Jul 15; 137(2):490-7. PubMed ID: 3522732 [Abstract] [Full Text] [Related]
9. Dissociation in expression of MB1/MT1 and DR1 alloantigens in mutants of a lymphoblastoid cell line. DeMars R, Chang CC, Marrari M, Duquesnoy RJ, Noreen H, Segall M, Bach FH. J Immunol; 1983 Sep 15; 131(3):1318-21. PubMed ID: 6411812 [Abstract] [Full Text] [Related]
10. HLA-DP can be expressed with or without -DR molecules on a malignant B cell line. Pesando JM, Graf L, Hoffman P. J Immunol; 1986 Sep 15; 137(6):1932-6. PubMed ID: 3489045 [Abstract] [Full Text] [Related]
12. Differential antigen-presenting cell requirements of hapten-specific T cell lines restricted to class II determinants. Hanke JH, Cook RG, Lopez LA, Rich RR. J Immunol; 1987 Apr 15; 138(8):2384-91. PubMed ID: 3494064 [Abstract] [Full Text] [Related]
13. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies. Maeda H, Hirata R, Okuyama M, Thompson A, Tohyama H. J Immunol; 1984 May 15; 132(5):2478-84. PubMed ID: 6201545 [Abstract] [Full Text] [Related]
14. Differential abilities of human peripheral blood monocytes quantitatively or qualitatively differing in HLA-DR and HLA-DS expression to support B cell activation in liquid and semisolid cultures. Whisler RL, Newhouse YG, Lachman LB. J Immunol; 1985 Jul 15; 135(1):172-9. PubMed ID: 3873488 [Abstract] [Full Text] [Related]
15. Differential Ia antigen expression by autologous human erythroid and B lymphoblastoid cell lines. Symington FW, Levine F, Braun M, Brown SL, Erlich HA, Torok-Storb B. J Immunol; 1985 Aug 15; 135(2):1026-32. PubMed ID: 3874223 [Abstract] [Full Text] [Related]
16. Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain. Hansson GK, Jonasson L, Holm J, Claesson-Welsh L. Clin Exp Immunol; 1986 May 15; 64(2):261-8. PubMed ID: 3527502 [Abstract] [Full Text] [Related]
19. Southern and oligonucleotide analyses of HLA-DQw1-associated DR1, DRw6, and DRw10 specificities in Asian Indians. Sood SK, D'Souza M, Singal DP. Transplant Proc; 1991 Feb 15; 23(1 Pt 1):459-60. PubMed ID: 1990585 [No Abstract] [Full Text] [Related]
20. Separation of four class II molecules from DR2 and DRw6 homozygous B lymphoid cell lines. Maeda H, Hirata R. Immunogenetics; 1984 Feb 15; 20(6):639-47. PubMed ID: 6392082 [Abstract] [Full Text] [Related] Page: [Next] [New Search]